Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Neoplasms | 69 | 2024 | 13249 | 6.490 |
Why?
|
Cryosurgery | 14 | 2024 | 473 | 5.610 |
Why?
|
Sarcopenia | 13 | 2024 | 372 | 4.420 |
Why?
|
Tomography, X-Ray Computed | 63 | 2024 | 20484 | 2.790 |
Why?
|
Early Detection of Cancer | 20 | 2024 | 3215 | 2.270 |
Why?
|
Pneumonectomy | 6 | 2021 | 1110 | 2.200 |
Why?
|
Body Composition | 12 | 2024 | 2418 | 2.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 14 | 2024 | 5248 | 1.790 |
Why?
|
Thoracic Wall | 3 | 2019 | 199 | 1.690 |
Why?
|
Catheter Ablation | 6 | 2023 | 2755 | 1.680 |
Why?
|
Muscle, Skeletal | 12 | 2023 | 4923 | 1.670 |
Why?
|
Ablation Techniques | 5 | 2024 | 249 | 1.660 |
Why?
|
Lung Diseases, Interstitial | 5 | 2023 | 907 | 1.630 |
Why?
|
Radiography, Interventional | 5 | 2024 | 1112 | 1.140 |
Why?
|
High-Frequency Jet Ventilation | 2 | 2024 | 26 | 1.080 |
Why?
|
Biopsy, Needle | 10 | 2024 | 1633 | 1.020 |
Why?
|
Lung | 24 | 2024 | 9989 | 0.970 |
Why?
|
Radiosurgery | 3 | 2024 | 1343 | 0.950 |
Why?
|
Radiography, Thoracic | 6 | 2020 | 1295 | 0.890 |
Why?
|
Radiographic Image Enhancement | 2 | 2021 | 880 | 0.820 |
Why?
|
Retrospective Studies | 46 | 2024 | 80301 | 0.810 |
Why?
|
Thoracic Neoplasms | 1 | 2024 | 265 | 0.770 |
Why?
|
Microwaves | 5 | 2023 | 184 | 0.750 |
Why?
|
Hemoptysis | 2 | 2021 | 152 | 0.730 |
Why?
|
Mass Screening | 7 | 2023 | 5422 | 0.680 |
Why?
|
Pneumonia | 6 | 2023 | 2138 | 0.670 |
Why?
|
Aged | 62 | 2024 | 168995 | 0.670 |
Why?
|
Humans | 137 | 2024 | 760261 | 0.650 |
Why?
|
Adipose Tissue | 3 | 2021 | 3293 | 0.640 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2021 | 262 | 0.620 |
Why?
|
Hyperthermia, Induced | 1 | 2022 | 415 | 0.610 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2019 | 270 | 0.580 |
Why?
|
Embolism, Air | 1 | 2017 | 110 | 0.580 |
Why?
|
Pleural Neoplasms | 2 | 2019 | 609 | 0.570 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2019 | 734 | 0.560 |
Why?
|
Middle Aged | 60 | 2024 | 220175 | 0.550 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 499 | 0.550 |
Why?
|
X-Ray Microtomography | 1 | 2018 | 444 | 0.540 |
Why?
|
Lung Diseases | 3 | 2024 | 1915 | 0.530 |
Why?
|
Radiology Information Systems | 2 | 2017 | 528 | 0.520 |
Why?
|
Male | 72 | 2024 | 359413 | 0.510 |
Why?
|
Female | 69 | 2024 | 391011 | 0.490 |
Why?
|
Catecholamines | 1 | 2015 | 385 | 0.480 |
Why?
|
Radiology | 5 | 2023 | 2103 | 0.460 |
Why?
|
Biopsy, Fine-Needle | 1 | 2019 | 1111 | 0.460 |
Why?
|
Adrenalectomy | 1 | 2015 | 348 | 0.450 |
Why?
|
Practice Management, Medical | 1 | 2015 | 191 | 0.440 |
Why?
|
Brachytherapy | 1 | 2021 | 1240 | 0.430 |
Why?
|
Aged, 80 and over | 28 | 2024 | 58947 | 0.430 |
Why?
|
Contrast Media | 5 | 2023 | 5301 | 0.420 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2359 | 0.420 |
Why?
|
Immunotherapy | 4 | 2020 | 4637 | 0.420 |
Why?
|
Postoperative Complications | 6 | 2024 | 15680 | 0.400 |
Why?
|
Body Mass Index | 8 | 2024 | 12901 | 0.400 |
Why?
|
Treatment Outcome | 17 | 2024 | 64947 | 0.380 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1411 | 0.370 |
Why?
|
Length of Stay | 6 | 2024 | 6472 | 0.360 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9196 | 0.360 |
Why?
|
Sarcoma | 1 | 2021 | 1786 | 0.350 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3223 | 0.350 |
Why?
|
Weight Loss | 2 | 2021 | 2683 | 0.350 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2017 | 951 | 0.340 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 1328 | 0.340 |
Why?
|
Thorax | 2 | 2023 | 553 | 0.340 |
Why?
|
Neoplasms | 8 | 2024 | 22066 | 0.320 |
Why?
|
Preoperative Care | 1 | 2017 | 2255 | 0.300 |
Why?
|
Jejunal Diseases | 1 | 2008 | 46 | 0.300 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4312 | 0.300 |
Why?
|
Critical Illness | 2 | 2017 | 2709 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2805 | 0.290 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2532 | 0.290 |
Why?
|
Palliative Care | 2 | 2019 | 3607 | 0.290 |
Why?
|
Diverticulum | 1 | 2008 | 137 | 0.280 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2557 | 0.270 |
Why?
|
Radiation Dosage | 4 | 2022 | 1957 | 0.270 |
Why?
|
Cysts | 2 | 2024 | 683 | 0.260 |
Why?
|
Fluoroscopy | 3 | 2022 | 943 | 0.250 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4317 | 0.250 |
Why?
|
Combined Modality Therapy | 5 | 2024 | 8551 | 0.240 |
Why?
|
Pain | 1 | 2019 | 5066 | 0.240 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 521 | 0.240 |
Why?
|
Forced Expiratory Volume | 2 | 2019 | 1810 | 0.230 |
Why?
|
Glycolates | 1 | 2023 | 40 | 0.230 |
Why?
|
Cardiac Imaging Techniques | 1 | 2016 | 269 | 0.220 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2011 | 1067 | 0.220 |
Why?
|
Prognosis | 9 | 2024 | 29636 | 0.210 |
Why?
|
Incidental Findings | 2 | 2019 | 698 | 0.210 |
Why?
|
Melanoma | 4 | 2024 | 5695 | 0.210 |
Why?
|
Cystatin C | 1 | 2024 | 270 | 0.210 |
Why?
|
Adult | 25 | 2024 | 219847 | 0.200 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15740 | 0.200 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2024 | 493 | 0.200 |
Why?
|
Antineoplastic Agents | 5 | 2024 | 13629 | 0.200 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Intensive Care Units | 4 | 2024 | 3737 | 0.190 |
Why?
|
Tomography | 2 | 2021 | 411 | 0.190 |
Why?
|
Hemothorax | 1 | 2021 | 57 | 0.190 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6457 | 0.190 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6855 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 7 | 2022 | 36247 | 0.190 |
Why?
|
Testicular Neoplasms | 2 | 2024 | 800 | 0.180 |
Why?
|
Biopsy | 4 | 2023 | 6775 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2023 | 9274 | 0.180 |
Why?
|
Cohort Studies | 7 | 2024 | 41317 | 0.170 |
Why?
|
Point-of-Care Systems | 2 | 2020 | 1208 | 0.170 |
Why?
|
Survival Analysis | 3 | 2021 | 10185 | 0.170 |
Why?
|
Hospitals | 3 | 2024 | 3929 | 0.170 |
Why?
|
Rotation | 1 | 2021 | 514 | 0.170 |
Why?
|
Acrylamides | 2 | 2018 | 260 | 0.170 |
Why?
|
Follow-Up Studies | 5 | 2023 | 39254 | 0.170 |
Why?
|
United States | 13 | 2023 | 72363 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5644 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 2 | 2021 | 6545 | 0.170 |
Why?
|
Enterocolitis | 1 | 2020 | 106 | 0.170 |
Why?
|
Subclavian Artery | 2 | 2017 | 133 | 0.160 |
Why?
|
Preoperative Period | 1 | 2021 | 555 | 0.160 |
Why?
|
Lung Injury | 1 | 2023 | 424 | 0.160 |
Why?
|
Reference Values | 2 | 2023 | 4920 | 0.160 |
Why?
|
Pulmonary Fibrosis | 1 | 2023 | 507 | 0.160 |
Why?
|
Smoking | 3 | 2024 | 9070 | 0.160 |
Why?
|
Creatinine | 1 | 2024 | 1906 | 0.150 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 371 | 0.150 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 15273 | 0.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2018 | 1215 | 0.150 |
Why?
|
Aspergillosis | 1 | 2020 | 243 | 0.150 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 612 | 0.150 |
Why?
|
Diagnostic Imaging | 3 | 2024 | 3526 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2018 | 66 | 0.150 |
Why?
|
Depression | 1 | 2017 | 8033 | 0.150 |
Why?
|
Pneumothorax | 1 | 2021 | 377 | 0.150 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2311 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2023 | 898 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 649 | 0.150 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 532 | 0.140 |
Why?
|
Respiration | 1 | 2024 | 1648 | 0.140 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2019 | 167 | 0.140 |
Why?
|
Access to Information | 1 | 2020 | 320 | 0.140 |
Why?
|
Wireless Technology | 1 | 2017 | 98 | 0.140 |
Why?
|
Disease Progression | 5 | 2024 | 13505 | 0.140 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 277 | 0.140 |
Why?
|
Adiposity | 2 | 2024 | 1851 | 0.130 |
Why?
|
Radiation Injuries | 1 | 2023 | 1183 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 936 | 0.130 |
Why?
|
Aniline Compounds | 2 | 2018 | 1068 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 422 | 0.130 |
Why?
|
Outpatients | 2 | 2022 | 1606 | 0.130 |
Why?
|
Internet | 3 | 2022 | 3074 | 0.130 |
Why?
|
Electric Impedance | 1 | 2020 | 751 | 0.130 |
Why?
|
Risk Factors | 9 | 2022 | 74269 | 0.130 |
Why?
|
Takayasu Arteritis | 1 | 2017 | 95 | 0.130 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2015 | 27 | 0.130 |
Why?
|
Quality of Life | 1 | 2017 | 13300 | 0.130 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1266 | 0.130 |
Why?
|
Internship and Residency | 3 | 2024 | 5867 | 0.130 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2178 | 0.130 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2017 | 287 | 0.130 |
Why?
|
Quadriceps Muscle | 1 | 2016 | 154 | 0.130 |
Why?
|
Fibrosis | 1 | 2022 | 2042 | 0.120 |
Why?
|
Photons | 1 | 2019 | 581 | 0.120 |
Why?
|
Obesity | 4 | 2024 | 12915 | 0.120 |
Why?
|
Positive-Pressure Respiration | 1 | 2019 | 634 | 0.120 |
Why?
|
Subcutaneous Fat | 1 | 2018 | 393 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2018 | 3335 | 0.120 |
Why?
|
Medical Record Linkage | 1 | 2016 | 289 | 0.120 |
Why?
|
Peroxidase | 1 | 2017 | 604 | 0.120 |
Why?
|
Survival Rate | 5 | 2019 | 12806 | 0.120 |
Why?
|
Morbidity | 1 | 2019 | 1765 | 0.120 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1405 | 0.120 |
Why?
|
Pleura | 1 | 2015 | 243 | 0.110 |
Why?
|
Thymoma | 1 | 2015 | 187 | 0.110 |
Why?
|
Celiac Disease | 1 | 2022 | 822 | 0.110 |
Why?
|
Time Factors | 6 | 2024 | 40133 | 0.110 |
Why?
|
Weight Gain | 1 | 2024 | 2347 | 0.110 |
Why?
|
Coronary-Subclavian Steal Syndrome | 1 | 2013 | 2 | 0.110 |
Why?
|
Substance Abuse, Intravenous | 1 | 2018 | 529 | 0.110 |
Why?
|
Societies, Medical | 2 | 2015 | 3903 | 0.110 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 25928 | 0.110 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12156 | 0.110 |
Why?
|
Clinical Competence | 2 | 2024 | 4786 | 0.110 |
Why?
|
Prescriptions | 1 | 2015 | 388 | 0.110 |
Why?
|
Anthropometry | 1 | 2018 | 1348 | 0.110 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 752 | 0.110 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2235 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2120 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 818 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 607 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2018 | 660 | 0.100 |
Why?
|
Models, Organizational | 1 | 2016 | 545 | 0.100 |
Why?
|
Colitis | 1 | 2021 | 1229 | 0.100 |
Why?
|
Prospective Studies | 6 | 2023 | 54263 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 747 | 0.100 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2015 | 385 | 0.100 |
Why?
|
Musculoskeletal Diseases | 1 | 2018 | 594 | 0.100 |
Why?
|
Neurilemmoma | 1 | 2017 | 523 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11708 | 0.100 |
Why?
|
Colon | 2 | 2020 | 1788 | 0.100 |
Why?
|
Risk | 1 | 2023 | 9629 | 0.100 |
Why?
|
Frail Elderly | 1 | 2016 | 747 | 0.090 |
Why?
|
Hospital Costs | 1 | 2017 | 976 | 0.090 |
Why?
|
Proportional Hazards Models | 3 | 2024 | 12532 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2021 | 2052 | 0.090 |
Why?
|
Thyrotropin | 1 | 2014 | 832 | 0.090 |
Why?
|
Workflow | 1 | 2016 | 851 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1001 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2334 | 0.090 |
Why?
|
Registries | 2 | 2018 | 8449 | 0.090 |
Why?
|
Lymph Nodes | 1 | 2022 | 3491 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2017 | 716 | 0.090 |
Why?
|
Retreatment | 1 | 2012 | 600 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3433 | 0.090 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12968 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 706 | 0.090 |
Why?
|
Medical Records | 1 | 2015 | 1407 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 1361 | 0.090 |
Why?
|
Risk Assessment | 4 | 2021 | 24086 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2016 | 698 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1897 | 0.080 |
Why?
|
Hypothyroidism | 1 | 2014 | 665 | 0.080 |
Why?
|
Focus Groups | 1 | 2015 | 1372 | 0.080 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 848 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3514 | 0.080 |
Why?
|
Patient Positioning | 1 | 2012 | 327 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4814 | 0.080 |
Why?
|
Neoplasm Staging | 5 | 2024 | 11141 | 0.080 |
Why?
|
Calcium | 1 | 2022 | 5726 | 0.080 |
Why?
|
Lipoma | 1 | 2011 | 292 | 0.080 |
Why?
|
Pilot Projects | 2 | 2019 | 8553 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2007 | 0.080 |
Why?
|
Respiratory Mechanics | 2 | 2024 | 698 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2018 | 5201 | 0.070 |
Why?
|
Artifacts | 2 | 2017 | 1893 | 0.070 |
Why?
|
Barium Sulfate | 1 | 2008 | 180 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3217 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2633 | 0.070 |
Why?
|
Cisplatin | 2 | 2024 | 1642 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14482 | 0.070 |
Why?
|
Sex Factors | 2 | 2018 | 10530 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 1867 | 0.070 |
Why?
|
Program Evaluation | 1 | 2015 | 2494 | 0.070 |
Why?
|
Research | 1 | 2015 | 1973 | 0.070 |
Why?
|
Massachusetts | 1 | 2019 | 8805 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4127 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8945 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2019 | 3598 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4024 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2931 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 1162 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2916 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3381 | 0.060 |
Why?
|
Dyspnea | 3 | 2020 | 1352 | 0.060 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2016 | 140 | 0.060 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2064 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 3023 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5324 | 0.060 |
Why?
|
Cough | 2 | 2020 | 595 | 0.060 |
Why?
|
Quality Assurance, Health Care | 2 | 2012 | 2178 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6310 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8018 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18415 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3327 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3762 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2013 | 1802 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1614 | 0.050 |
Why?
|
Odds Ratio | 1 | 2015 | 9712 | 0.050 |
Why?
|
Inflammation | 2 | 2023 | 10757 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2250 | 0.050 |
Why?
|
Incidence | 2 | 2020 | 21378 | 0.050 |
Why?
|
Gallium Radioisotopes | 1 | 2023 | 194 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9468 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3278 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 258 | 0.050 |
Why?
|
Manometry | 1 | 2024 | 453 | 0.050 |
Why?
|
Multimedia | 1 | 2022 | 74 | 0.050 |
Why?
|
Health Personnel | 1 | 2015 | 3310 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3924 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 14656 | 0.050 |
Why?
|
Mutation | 3 | 2021 | 29950 | 0.050 |
Why?
|
Pressure | 1 | 2024 | 1155 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7809 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5396 | 0.050 |
Why?
|
Tomography, Spiral Computed | 1 | 2022 | 273 | 0.050 |
Why?
|
Logistic Models | 1 | 2015 | 13311 | 0.050 |
Why?
|
Search Engine | 1 | 2022 | 140 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2469 | 0.040 |
Why?
|
Collagen Type I | 1 | 2023 | 615 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2024 | 419 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3840 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9945 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4875 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4763 | 0.040 |
Why?
|
Curriculum | 2 | 2024 | 3722 | 0.040 |
Why?
|
Cell Growth Processes | 1 | 2019 | 384 | 0.040 |
Why?
|
Prone Position | 1 | 2019 | 196 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 635 | 0.040 |
Why?
|
Keratin-8 | 1 | 2017 | 11 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7468 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2023 | 1041 | 0.040 |
Why?
|
Young Adult | 3 | 2024 | 58673 | 0.040 |
Why?
|
Keratin-18 | 1 | 2017 | 38 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1305 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20048 | 0.040 |
Why?
|
Lactams | 1 | 2017 | 154 | 0.040 |
Why?
|
Thrombocytosis | 1 | 2017 | 82 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 13967 | 0.040 |
Why?
|
Molecular Imaging | 1 | 2023 | 817 | 0.030 |
Why?
|
Sweating | 1 | 2017 | 154 | 0.030 |
Why?
|
Iopamidol | 1 | 2016 | 186 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 250 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2017 | 315 | 0.030 |
Why?
|
Radiography | 2 | 2020 | 6965 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21065 | 0.030 |
Why?
|
Erythema | 1 | 2017 | 262 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2295 | 0.030 |
Why?
|
Collagen | 1 | 2023 | 2635 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1833 | 0.030 |
Why?
|
Lumbosacral Region | 1 | 2016 | 291 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1523 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2893 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3531 | 0.030 |
Why?
|
Hoarseness | 1 | 2014 | 62 | 0.030 |
Why?
|
Sacrum | 1 | 2016 | 281 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 280 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2016 | 4560 | 0.030 |
Why?
|
Aminopyridines | 1 | 2017 | 564 | 0.030 |
Why?
|
Heart Failure | 1 | 2018 | 11835 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4891 | 0.030 |
Why?
|
Rhabdomyolysis | 1 | 2014 | 155 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2017 | 697 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2473 | 0.030 |
Why?
|
Aspartate Aminotransferases | 1 | 2014 | 415 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2061 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 220 | 0.030 |
Why?
|
Fibromyalgia | 1 | 2017 | 398 | 0.030 |
Why?
|
Eosinophilia | 1 | 2017 | 560 | 0.030 |
Why?
|
Creatine Kinase | 1 | 2014 | 691 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 597 | 0.030 |
Why?
|
Exons | 1 | 2018 | 2391 | 0.030 |
Why?
|
Polypharmacy | 1 | 2014 | 307 | 0.020 |
Why?
|
Thyroid Hormones | 1 | 2014 | 403 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 943 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3568 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3826 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2015 | 604 | 0.020 |
Why?
|
Travel | 1 | 2017 | 786 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8621 | 0.020 |
Why?
|
Thyroxine | 1 | 2014 | 667 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1430 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2689 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6131 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4292 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1249 | 0.020 |
Why?
|
Nursing Homes | 1 | 2016 | 1076 | 0.020 |
Why?
|
Diarrhea | 1 | 2015 | 1341 | 0.020 |
Why?
|
Skin Diseases | 1 | 2017 | 1089 | 0.020 |
Why?
|
Automation | 1 | 2010 | 581 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6830 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1511 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1544 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1992 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4276 | 0.020 |
Why?
|
Piperazines | 1 | 2017 | 2520 | 0.020 |
Why?
|
Pyridines | 1 | 2017 | 2877 | 0.020 |
Why?
|
Bone Marrow | 1 | 2015 | 2918 | 0.020 |
Why?
|
Boston | 1 | 2018 | 9282 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5797 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7592 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4081 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4168 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5230 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3967 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2010 | 1402 | 0.010 |
Why?
|
Medication Adherence | 1 | 2014 | 2163 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5420 | 0.010 |
Why?
|
Spinal Cord | 1 | 2011 | 1817 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6771 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10761 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3333 | 0.010 |
Why?
|
Brain | 2 | 2020 | 26912 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2020 | 8984 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81216 | 0.010 |
Why?
|
Software | 1 | 2010 | 4420 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42034 | 0.010 |
Why?
|
Animals | 1 | 2023 | 167940 | 0.010 |
Why?
|